As part of its mission to strengthen healthcare delivery in Nigeria through collaboration with key stakeholders, the House of Representatives Committee on HIV/AIDS, Tuberculosis, and Malaria (ATM) paid a courtesy visit to Shalina Healthcare’s state-of-the-art factory at OPIC, Lagos-Ibadan Motorway, recently.
The delegation, led by the Deputy Chairman of the House Committee, Hon. Abubakar Babazango, who represented the Committee Chairman, Hon. Amobi Godwin Ogah, was warmly received by Shalina Healthcare Nigeria’s Managing Director, Opeyemi Akinyele, alongside other senior company officials.
During the visit, committee members were given a guided tour of the facility, where they were briefed on Shalina’s operations, product lines, and unwavering commitment to quality and safety in pharmaceutical production.
The tour provided the committee with insights into how Shalina’s products, particularly its over-the-counter medications and prescription drugs, are developed, manufactured, and distributed across the country and beyond. The company’s investment in state-of-the-art technology and adherence to global best practices in pharmaceutical manufacturing were highlighted as pivotal to its success in the Nigerian market.
Speaking after the tour, Babazango praised Shalina Healthcare for its valuable contributions to Nigeria’s healthcare sector. He encouraged the company to maintain its high standards and expressed the need for stronger public-private partnerships to enhance healthcare delivery in the country.
“Partnerships between the House of Representatives Committee on HIV/AIDS, Tuberculosis, and Malaria and private sector entities like Shalina Healthcare are essential for achieving improved healthcare outcomes in Nigeria,” said Babazango, who represents Yola North/Yola South/Girei Federal Constituency in the 10th House of Representatives.
In her remarks, Managing Director, Shalina Healthcare, Nigeria, Opeyemi Akinyele, expressed appreciation for the committee’s visit, reaffirming Shalina’s dedication to supporting government initiatives aimed at enhancing healthcare delivery.
Shalina’s boss highlighted the company’s ongoing investments in healthcare infrastructure, innovative product development, and community outreach programs.
The House of Representatives Committee delegation included Hon. Abubakar Babazango, deputy chairman of the House Committee on HIV/AIDS, Tuberculosis, and Malaria; Hon. Olusola Steve Fatoba; and Ms. Aneke Nnenna Gladysmary, national assembly clerk of the committee.
On the other hand, Shalina Healthcare delegation was joined by Bharat Pahuja, head of finance, West Africa; Pharm. (Chief) Emeka Adimoha, pharma director and regulatory head; Pharm. Sandeep Sahu, head of sales, Nigeria Pharma Trade; and Pharm. Shakiru Makinde, head of plant operations.
The visit comes just two months after the House Committee advocated for the allocation of one percent of the Consolidated Revenue of the Federal Government to combat HIV/AIDS and other public health diseases, underscoring the committee’s focus on ensuring sufficient resources for critical healthcare challenges.
 paid a courtesy visit to Shalina Healthcare’s state){kind=link}